Dr. Matthew Curtiss Lafleur, MD

Dr. Lafleur practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Lafleur's NPI, 1780853127, was assigned on February 29, 2008. Dr. Lafleur holds Louisiana license PGY-2.

Dr. Lafleur's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Lafleur's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Lafleur is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Lafleur to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lafleur practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Lafleur's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Lafleur is licensed in Louisiana.

CMS data shows 132 Medicare services from Dr. Lafleur across 4 procedure codes in 2024, for 92 Medicare patients. Medicare paid $8,605 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 92 Medicare patients who saw Dr. Lafleur in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have arthritis, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lafleur's median patient age at 57, with 62% women.

In 2024, Dr. Lafleur wrote 271 Medicare Part D claims for 73 patients. 100% of them were for generic drugs. CMS names the drug for 220 of them, across 6 drugs with 11 or more claims each, at $2,951 in total drug cost. In 2023, CMS named 265 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Lafleur for performance year 2024, reported as part of a group. Dr. Lafleur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of spinal fusion by Dr. Lafleur, more than 39% of the clinicians it reports for that procedure.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Lafleur in 2013. Dr. Lafleur's most frequent co-authors are David A. Joyner, MD and Majid Aziz Khan, MD.

CMS Open Payments shows 139 general payments to Dr. Lafleur from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Medical Device Business Services, Inc. paid the most, $1,467.